By Fineline Cube China-based Ascletis Pharma Inc. (HKG: 1672) has announced the appointment of Mr. John P. Gargiulo as its new Chief Business Officer (CBO). Formerly the North America President and CEO for Daiichi Sankyo, Gargiulo will lead Ascletis’s corporate business development and alliance management, reporting to Dr. Jinzi J. Wu, PhD, founder, chairman, and CEO of Ascletis.
Gargiulo’s Experience and Background
Gargiulo brings over 30 years of successful experience in marketing strategies, business integration, and commercial operations in the global pharma/biotech industry. During his 18-year tenure at Daiichi Sankyo, he played a transformative role in driving the company’s US business from its initial stages to becoming an established pharma entity. His leadership as North America President and CEO was instrumental in this growth.
Educational Credentials
Gargiulo earned an MBA and graduated as a Fuqua Scholar from the Fuqua School of Business at Duke University. He also graduated Magna cum Laude from Boston College with a bachelor’s degree in economics.-Fineline Info & Tech